Sure - saw Biocryst dive big time, but they are still way overpriced and sitting at an MC of approx $US150m...
...unbelievable how they can still be maintaining this sort of value based on vapour - at least by comparison with where other biotechs in their space are.
Ridiculous pipeline and stages where they are at.
- Forums
- ASX - By Stock
- BTA
- rsv fda fastrack
rsv fda fastrack, page-6
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)